Alira Health

EPP Life Sciences Pricing Forum 2024

October 9-11, 2024 | Berlin, Germany

We are excited to share that we will speak at the EPP Life Sciences Pricing Forum, the must-attend conference for pricing directors and executives, and all of those involved in pricing, market access and reimbursement for the pharmaceutical, medtech and biotech industries.

Be sure to attend our presentation, “Big Data, Digital Analytics, and AI in Market Access and Pricing Operations,” with Andrea Mantovani.

Want to connect at EPP Life Sciences Pricing Forum? Contact us to set up a meeting! 

Join Our Presentation!

Big Data, Digital Analytics, and AI in Market Access and Pricing Operations

October 10 | 1 PM

Speaker: Andrea Mantovani, Partner, Market Access and Pricing, Alira Health

Discover how big data, digital analytics, and AI are transforming market access and pricing strategies in the life sciences. This presentation will explore practical approaches to leveraging these technologies to optimize operations, drive data-driven decision-making, and enhance pricing models. Attendees will learn how real-time market intelligence, powered by big data, enables agile responses to market trends and regulatory shifts. We will also analyze how digital analytics can refine pricing strategies, while AI solutions can revolutionize predictive modelling and strategic planning through successful case studies. Join us to explore the future of market access and pricing, where advanced analytics and AI unlock new growth opportunities.

About Our Speaker

Andrea Mantovani

Andrea Mantovani
Partner, Market Access and Pricing

Andrea Mantovani has more than 25 years of management consulting and pharmaceutical industry experience. His expertise is in strategy, marketing and sales, public affairs, pricing, and market access. Andrea’s work focuses on international projects across therapeutic areas, including oncology, haematology, cardiometabolic, immunology, and rare diseases. Prior to joining Alira Health, Andrea worked at Andersen Consulting (now Accenture) and held senior management roles for big pharma companies in the UK, Spain, and Italy, including Sanofi and Novartis, where he spent five years at the international headquarters, overseeing activities in 28 countries and spearheading transformational Value and Access projects. Andrea holds a degree in marketing and economics from the University of Verona, and an MBA from SDA Bocconi Business School, with focus on healthcare and pharmaceuticals. He has received additional training in economics, pharmacoeconomics, and digital transformation in well renowned business schools. He is also a contract professor for Innovation, Market Access and Public Affairs at LUISS Business School and an external lecturer for the MAMIL Master, and MAMAF Master, from Pavia University. 

Discover Our Market Access Expert Materials

White Paper

Download this white paper to learn about ATMPs challenges in access and commercialization, existing and future innovative solutions for ATMPs access,
and patient views on ATMPs and ethical considerations.

Learn more 

Case Study

A US biopharma company needed to validate the patient journeys and US reimbursement pathways for their two alpha-emitting radioligand therapies (RLT) in two solid tumor indications.

Learn more 

Case Study

In preparation for submitting their Phase III protocol to the FDA and the EMA, a multinational pharma sought support to incorporate early payer advice on the MG clinical trial design, identify evidence gaps, and provide insights on the development program.

Learn more

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.